+ Follow MINI-MENTAL STATE EXAMINATION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 891424
[Title] => New imaging agent correlates amyloid with Alzheimer’s
[Summary] => Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.
[DatePublished] => 2012-12-30 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 529563
[Title] => Blood test may identify Alzheimer's disease
[Summary] => A simple blood test could soon allow clinicians — even primary care physicians — to diagnose Alzheimer’s disease accurately if a final validation study succeeds as optimistic researchers hope.
[DatePublished] => 2009-12-06 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 211813
[Title] => Cholinesterase inhibitors: The earlier, the better
[Summary] => Cholinesterase inhibitor treatment should be started as early as possible in the course of dementia and continued as long as the perception of benefit outweighs the cost and side-effect profile. Decisions about which cholinesterase inhibitors to use in which patients, when to start using them, and whether to stop using them are "empirical", based on negotiation between the patient, physician, and family. They offered his recommendations based on the published data and common practice of dementia specialists in the United States and Europe.
[DatePublished] => 2003-06-29 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
MINI-MENTAL STATE EXAMINATION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 891424
[Title] => New imaging agent correlates amyloid with Alzheimer’s
[Summary] => Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.
[DatePublished] => 2012-12-30 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 529563
[Title] => Blood test may identify Alzheimer's disease
[Summary] => A simple blood test could soon allow clinicians — even primary care physicians — to diagnose Alzheimer’s disease accurately if a final validation study succeeds as optimistic researchers hope.
[DatePublished] => 2009-12-06 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 211813
[Title] => Cholinesterase inhibitors: The earlier, the better
[Summary] => Cholinesterase inhibitor treatment should be started as early as possible in the course of dementia and continued as long as the perception of benefit outweighs the cost and side-effect profile. Decisions about which cholinesterase inhibitors to use in which patients, when to start using them, and whether to stop using them are "empirical", based on negotiation between the patient, physician, and family. They offered his recommendations based on the published data and common practice of dementia specialists in the United States and Europe.
[DatePublished] => 2003-06-29 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
